Patents by Inventor Morten Wurtz Christensen
Morten Wurtz Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9593352Abstract: A method for producing fatty acid alkyl esters, wherein a solution comprising triglyceride and alcohol is contacted with a first lipolytic enzyme having a relatively higher activity on free fatty acids than on triglyceride and a second lipolytic enzyme having a relatively higher activity on triglyceride than on free fatty acids.Type: GrantFiled: April 28, 2011Date of Patent: March 14, 2017Assignee: Novozymes A/SInventors: Masnobu Abo, Morten Wurtz Christensen, Zhengyu Hu
-
Patent number: 9303256Abstract: The present invention relates to the immobilization of enzymes by adsorbing enzymes, a polyfunctional amine and a cross-linking agent onto a particulate porous carrier in a mixer apparatus or in a fluid bed apparatus.Type: GrantFiled: October 2, 2006Date of Patent: April 5, 2016Assignee: Novozymes A/SInventors: Isabelle Mazeaud, Poul Borge Rosenius Poulsen, Morten Wurtz Christensen, Jesper Brask
-
Patent number: 8178326Abstract: The invention relates to the utilization of fatty materials with substantial free fatty acid content in the production of biodiesel by the use of microbial enzymes that are effective in a solvent-free process for the production of esters of fatty acids and C1-C3 alkyl alcohols.Type: GrantFiled: April 9, 2008Date of Patent: May 15, 2012Assignees: Novozymes A/S, N.V. Desmet Ballestra Group S.A.Inventors: Wim De Greyt, Marc Kellens, Hans Christian Holm, Morten Wurtz Christensen, Per Munk Nielsen
-
Patent number: 8071757Abstract: A hyaluronic acid derivative, and methods of producing and using said derivative, the derivative comprising n repeating units and having the general structural formula (I), wherein, in at least one repeating unit, one or more of R1, R2, R3, R4 comprises an etherbound aryl/alkyl sulfone having the general structural formula (II), wherein R comprises an alkyl- or aryl-group, and otherwise R1, R2, R3, R4 are hydroxyl groups, OH.Type: GrantFiled: March 2, 2007Date of Patent: December 6, 2011Assignee: Novozymes Biopharma DK A/SInventors: Corinne Eenschooten, Morten Würtz Christensen
-
Publication number: 20110257123Abstract: A hyaluronic acid derivative, and methods of producing and using said derivative, the derivative comprising n repeating units and having the general structural formula (I), wherein, in at least one repeating unit, one or more of R1, R2, R3, R4 comprises an etherbound aryl/alkyl sulfone having the general structural fomula (II), wherein R comprises an alkyl- or aryl-group, and otherwise R1, R2, R3, R4 are hydroxyl groups, OH.Type: ApplicationFiled: March 2, 2007Publication date: October 20, 2011Applicant: Novozymes Biopolymer A/SInventors: Corinne Eenschooten, Morten Wurtz Christensen
-
Patent number: 8012724Abstract: The present invention relates to a method for producing fatty acid alkyl esters, such as fatty acid methyl esters (FAME) and fatty acid ethyl esters with a low level of impurities such as phospholipids. The method of the invention is simplified by combining two process steps into one single process step and is therefore economically cheaper. The method includes mixing water, alcohol, triglyceride and/or free fatty acids a lipolytic enzyme and a phospholipase. Subsequently the aqueous phase, which contains glycerine, residual enzyme and most of the hydrolyzed phospholipids, is separated from the non-aqueous phase, whereby the content of phospholipids in the non-aqueous phase is reduced.Type: GrantFiled: June 13, 2006Date of Patent: September 6, 2011Assignee: Novozymes A/SInventors: Hans Christian Holm, Per Munk Nielsen, Morten Wurtz Christensen
-
Publication number: 20110201066Abstract: A method for producing fatty acid alkyl esters, wherein a solution comprising triglyceride and alcohol is contacted with a first lipolytic enzyme having a relatively higher activity on free fatty acids than on triglyceride and a second lipolytic enzyme having a relatively higher activity on triglyceride than on free fatty acids.Type: ApplicationFiled: April 28, 2011Publication date: August 18, 2011Applicant: Novozymes A/SInventors: Masnobu Abo, Morten Wurtz Christensen, Zhengyu Hu
-
Publication number: 20100047884Abstract: The invention relates to the utilisation of fatty materials with substantial free fatty acid content in the production of biodiesel by the use of microbial enzymes that are effective in a solvent-free process for the production of esters of fatty acids and C1-C3 alkyl alcohols.Type: ApplicationFiled: April 9, 2008Publication date: February 25, 2010Applicant: Novozymes A/SInventors: Wim De Greyt, Marc Kellens, Hans Christian Holm, Morten Wurtz Christensen, Per Munk Nielsen
-
Publication number: 20080199924Abstract: The present invention relates to a method for producing fatty acid alkyl esters, such as fatty acid methyl esters (FAME) and fatty acid ethyl esters with a low level of impurities such as phospholipids. The method of the invention is simplified by combining two process steps into one single process step and is therefore economically cheaper The method includes mixing water, alcohol, triglyceride and/or free fatty acids a lipolytic enzyme and a phospholipase. Subsequently the aqueous phase, which contains glycerine, residual enzyme and most of the hydrolyzed phospholipids, is separated from the non-aqueous phase, whereby the content of phospholipids in the non-aqueous phase is reduced.Type: ApplicationFiled: June 13, 2006Publication date: August 21, 2008Applicant: Novozymes A/SInventors: Hans Christian Holm, Per Munk Nielson, Morten Wurtz Christensen
-
Publication number: 20080113419Abstract: A method for producing fatty acid alkyl esters, wherein a solution comprising triglyceride and alcohol is contacted with a first lipolytic enzyme having a relatively higher activity on free fatty acids than on triglyceride and a second lipolytic enzyme having a relatively higher activity on triglyceride than on free fatty acids.Type: ApplicationFiled: January 10, 2006Publication date: May 15, 2008Applicant: Novozymes A/SInventors: Masanobu Abo, Morten Wurtz Christensen
-
Publication number: 20030203457Abstract: A process for producing an immobilized enzyme preparation for use in a mainly organic medium devoid of free water comprising using a fluid bed.Type: ApplicationFiled: May 9, 2003Publication date: October 30, 2003Applicant: Novozymes A/SInventors: Morten Wurtz Christensen, Ole Kirk, Christian Pedersen
-
Patent number: 6582942Abstract: An immobilized enzyme is prepared for use in organic mediums essentially devoid of free water. An enzyme-containing liquid medium is contacted with a particulate porous carrier which preferably has a particle size of 200-1000 &mgr;m and a surface area of 20-1000 m2/g to adsorb the enzyme on the carrier, and volatile components of the liquid medium contained by the carrier are removed. The carrier may have a hydrophilic surface, and an amount of liquid medium is used to prevent agglomeration of the carrier. Alternatively, the carrier has a hydrophobic surface, and the addition of a hygroscopic substance suppresses agglomeration of the carrier by absorbing excess liquid. The hygroscopic substance may be removed during the removal of volatile components. Contacting of the enzyme-containing liquid and carrier can be in a fluidized bed where immobilization and removing volatile components are conducted simultaneously, or contacting can be in mixer followed by removing volatile components in a fluidized bed.Type: GrantFiled: August 29, 2000Date of Patent: June 24, 2003Assignee: Novozymes A/SInventors: Morten Würtz Christensen, Ole Kirk, Christian Pedersen
-
Patent number: 6156548Abstract: An immobilized enzyme preparation for use in an organic medium essentially devoid of free water is prepared using a fluidized bed. An enzyme-containing liquid medium is contacted with a particulate porous carrier which preferably has a particle size of 200-1000 .mu.m and a surface area of 20-1000 m.sup.2 /g, and volatile components of the liquid medium are removed to fix or adsorb the enzyme on the carrier. The carrier may have a hydrophilic surface and an amount of liquid medium is used to prevent agglomeration of the carrier. The enzyme can be adsorbed on a carrier having a hydrophobic surface, and the addition of a hygroscopic substance suppresses agglomeration of the carrier by absorbing excess liquid. The hygroscopic substance may be removed during the removal of volatile components.Type: GrantFiled: December 11, 1998Date of Patent: December 5, 2000Assignee: Novo Nordisk A/SInventors: Morten Wurtz Christensen, Ole Kirk, Christian Pedersen